← Back to headlines
Cyclerion Therapeutics Merges with Korsana Biosciences for Alzheimer’s Research
Cyclerion Therapeutics (CYCN) has merged with Korsana Biosciences with the aim of advancing their pipeline for Alzheimer's disease treatments.
20 Apr, 14:15 — 20 Apr, 14:15
Sources
Showing 1 of 1 sources
Related Stories
EU Approves Revolutionary Pancreatic Cancer Treatment Improving Survival Rates
29m ago
Study Links Shingles Vaccine to Reduced Risk of Heart Attack and Stroke
40m ago
Actress Busy Philipps Reveals Successful Removal of Rare Brain Tumor
1h ago
Ras Al Khaimah Launches Fitness Challenge With 50,000 Dirham Prize
1h ago